Clinical Trial

Exercise for the Treatment of Cancer-Related Sarcopenia

Study acronym: HERA
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
Our primary objective is to assess the effects of exercise on cancer-related sarcopenia and its hallmarks, including muscle strength, muscle mass, and physical performance. The secondary objectives are to examine exercise adherence and the effects of exercise on health-related quality of life (QoL), cancer-related fatigue, and sleep quality. Additionally, we will explore the effects of exercise on bone and fat mass as secondary outcomes.
Trial Details
NCT Number NCT07498985
Lead Sponsor State University of Londrina
Conditions Cancer, Sarcopenia
Enrollment 78 participants
Start Date 2026-04-01
Primary Completion 2028-04 (estimated)
Study Completion 2028-12 (estimated)
Updated on ClinicalTrials.gov 2026-03-27